| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Sparsomycin
CAS:1404-64-4
Purity:>95%
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:Sparsomycin
CAS:1404-64-4
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
- Sparsomycin
-
- $473.00
-
2026-07-15
- CAS:1404-64-4
- Purity:
- Supply Ability: 10g
|
| | SPARSOMYCIN Basic information |
| Product Name: | SPARSOMYCIN | | Synonyms: | Aids-012106;B 120121L19;nsc59729;sparsomycin;Sparsomycin from Streptomyces sparsogenes;(E)-N-[(S)-1-(Hydroxymethyl)-2-[[(methylthio)methyl]sulfinyl]ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxopyrimidine-5-yl)propenamide;U-19183;2-Propenamide, N-[(1S)-1-(hydroxymethyl)-2-[(R)-[(methylthio)methyl]sulfinyl]ethyl]-3-(1,2,3,4-tetrahydro-6-methyl-2,4-dioxo-5-pyrimidinyl)-, (2E)- | | CAS: | 1404-64-4 | | MF: | C13H19N3O5S2 | | MW: | 361.44 | | EINECS: | | | Product Categories: | | | Mol File: | 1404-64-4.mol |  |
| | SPARSOMYCIN Chemical Properties |
| Melting point | 208-209° (dec) | | alpha | D25 +69° (c = 0.5 in water) | | density | 1.3893 (rough estimate) | | refractive index | 1.6390 (estimate) | | storage temp. | 2-8°C | | solubility | DMF: soluble,DMSO: soluble,Ethanol: soluble,Methanol: soluble | | form | A solid | | pka | 8.67 in water, 9.05 in 40% ethanol | | color | White to off-white |
| Hazard Codes | T+ | | Risk Statements | 28 | | Safety Statements | 28-36/37-45 | | RIDADR | UN 2811 6.1/PG 2 | | RTECS | WG5850000 | | Toxicity | LD50 in dogs, rats, mice (mg/kg): 0.5-1.0, 2.25, 4.32 i.v. (Ottenheijm, 1986); LD50 i.p. in mice: 2.4 mg/kg (Owen) |
| | SPARSOMYCIN Usage And Synthesis |
| Description | Sparsomycin is a bacterial metabolite and a nucleoside analog of uracil that has been found in S. sparsogenes and has diverse biological activities. It is active against KB carcinoma cells, Gram-positive and Gram-negative bacteria, and fungi. Sparsomycin is an inhibitor of peptidyl transferase that interferes with tRNA binding to the A-site of the peptidyl transfer center and increases the binding of peptidyl-tRNA to the P-site. It inhibits protein synthesis in bacteria, archaea, and eukaryotes. Sparsomycin reduces tumor growth in a P388 mouse leukemia model and in a Walker 256 carcinosarcoma rat model. | | Uses | Research tool for studying protein biosynthesis. | | Uses | Sparsomycin is an antibiotic that binds to active site and exit tunnel hydrophobic crevices of peptidyltransferase center of Haloarcula marismortui large ribosomal subunit. | | References | [1] H C OTTENHEIJM. Chemical and biological aspects of sparsomycin, an antibiotic from Streptomyces.[J]. Progress in medicinal chemistry, 1986, 23: 219-268. DOI: 10.1016/s0079-6468(08)70344-8
[2] E. LAZARO . Chemical, biochemical and genetic endeavours characterizing the interaction of sparsomycin with the ribosome[J]. Biochimie, 1991, 73 7: Pages 1137-1143. DOI: 10.1016/0300-9084(91)90157-v
[3] D J MASON R M S A DIETZ. Actinospectacin, a new antibiotic. I. Discovery and biological properties.[J]. Antibiotics & chemotherapy (Northfield, Ill.), 1961, 11: 118-122.
[4] Z ZYLICZ. In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor models.[J]. Investigational New Drugs, 1988, 6 4: 285-292. DOI: 10.1007/bf00173646 |
| | SPARSOMYCIN Preparation Products And Raw materials |
|